JP2022525208A5 - - Google Patents
Info
- Publication number
- JP2022525208A5 JP2022525208A5 JP2021555491A JP2021555491A JP2022525208A5 JP 2022525208 A5 JP2022525208 A5 JP 2022525208A5 JP 2021555491 A JP2021555491 A JP 2021555491A JP 2021555491 A JP2021555491 A JP 2021555491A JP 2022525208 A5 JP2022525208 A5 JP 2022525208A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna
- nucleotides
- rna
- compound
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025081846A JP2025156319A (ja) | 2019-03-15 | 2025-05-15 | 組織特異的なapoe調節のためのオリゴヌクレオチド |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819189P | 2019-03-15 | 2019-03-15 | |
| US62/819,189 | 2019-03-15 | ||
| US201962864797P | 2019-06-21 | 2019-06-21 | |
| US62/864,797 | 2019-06-21 | ||
| US201962951441P | 2019-12-20 | 2019-12-20 | |
| US62/951,441 | 2019-12-20 | ||
| PCT/US2020/022748 WO2020190768A1 (en) | 2019-03-15 | 2020-03-13 | Oligonucleotides for tissue specific apoe modulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025081846A Division JP2025156319A (ja) | 2019-03-15 | 2025-05-15 | 組織特異的なapoe調節のためのオリゴヌクレオチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525208A JP2022525208A (ja) | 2022-05-11 |
| JP2022525208A5 true JP2022525208A5 (cg-RX-API-DMAC7.html) | 2023-03-17 |
| JP7687685B2 JP7687685B2 (ja) | 2025-06-03 |
Family
ID=72520528
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555491A Active JP7687685B2 (ja) | 2019-03-15 | 2020-03-13 | 組織特異的なapoe調節のためのオリゴヌクレオチド |
| JP2025081846A Pending JP2025156319A (ja) | 2019-03-15 | 2025-05-15 | 組織特異的なapoe調節のためのオリゴヌクレオチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025081846A Pending JP2025156319A (ja) | 2019-03-15 | 2025-05-15 | 組織特異的なapoe調節のためのオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200362341A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3937951A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7687685B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113811311A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020239987A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133241A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020190768A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3929293A3 (en) | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| WO2017030973A1 (en) | 2015-08-14 | 2017-02-23 | University Of Massachusetts | Bioactive conjugates for oligonucleotide delivery |
| WO2018237245A1 (en) | 2017-06-23 | 2018-12-27 | University Of Massachusetts | TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS |
| BR112021002440A2 (pt) | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| WO2020041769A1 (en) | 2018-08-23 | 2020-02-27 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| KR20220047989A (ko) | 2019-08-09 | 2022-04-19 | 유니버시티 오브 매사추세츠 | Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드 |
| US20210115442A1 (en) * | 2019-08-23 | 2021-04-22 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| KR20220107243A (ko) | 2019-11-25 | 2022-08-02 | 코넬 유니버시티 | Apoe 유전자 요법 |
| JP7844347B2 (ja) * | 2020-04-27 | 2026-04-13 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | アポリポタンパク質E(ApoE)iRNA剤組成物およびその使用方法 |
| CA3174079A1 (en) | 2020-05-26 | 2021-12-02 | Anastasia Khvorova | Synthetic oligonucleotides having regions of block and cluster modifications |
| CN114716518A (zh) * | 2021-01-06 | 2022-07-08 | 圣诺制药公司 | 一种能够抑制pcsk9表达的分子构造及药物组合物 |
| US20240175028A1 (en) * | 2021-03-05 | 2024-05-30 | Alnylam Pharmaceuticals, Inc | DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNA |
| EP4313075A4 (en) * | 2021-03-24 | 2025-06-18 | Atalanta Therapeutics, Inc. | DOUBLE-STRANDED SIRNA WITH PATTERNED CHEMICAL MODIFICATIONS |
| WO2022271666A1 (en) * | 2021-06-22 | 2022-12-29 | University Of Massachusetts | OLIGONUCLEOTIDES FOR IFN-γ SIGNALING PATHWAY MODULATION |
| WO2023086777A1 (en) * | 2021-11-09 | 2023-05-19 | Children's National Medical Center | Targeting apoe enhances t-cell killing in cancer immunotherapy |
| JP2025532984A (ja) * | 2022-09-30 | 2025-10-03 | ユニバーシティー オブ マサチューセッツ | オリゴヌクレオチドの眼送達 |
| WO2024233864A2 (en) * | 2023-05-10 | 2024-11-14 | Dicerna Pharmaceuticals, Inc. | Galnac-conjugated rnai oligonucleotides |
| WO2025213111A2 (en) * | 2024-04-05 | 2025-10-09 | Cornell University | Aav expression of mirna to suppress human apoe mrna |
| WO2025240846A1 (en) * | 2024-05-17 | 2025-11-20 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating apoe expression |
| CN118460654B (zh) * | 2024-07-10 | 2025-02-14 | 凯莱英医药集团(天津)股份有限公司 | 一种Givosiran的制备方法 |
| WO2026057066A1 (zh) * | 2024-09-14 | 2026-03-19 | 瑞典瑞博科尔制药公司 | 寡核苷酸、寡核苷酸缀合物及组合物和用途 |
| WO2026067590A1 (zh) * | 2024-09-27 | 2026-04-02 | 南京金斯瑞生物科技有限公司 | 修饰的双链rna分子 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| US20060257851A1 (en) * | 2002-11-26 | 2006-11-16 | Itzhak Bentwich | Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
| US8362229B2 (en) * | 2006-02-08 | 2013-01-29 | Quark Pharmaceuticals, Inc. | Tandem siRNAS |
| EP1991252A2 (en) * | 2006-02-21 | 2008-11-19 | Oklahoma Medical Research Foundation | Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor |
| US8178503B2 (en) * | 2006-03-03 | 2012-05-15 | International Business Machines Corporation | Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes |
| US20100310553A1 (en) * | 2006-08-14 | 2010-12-09 | Guangxiang Luo | Compositions and Methods for Controlling Hepatitis C Virus Infection |
| US8431692B2 (en) * | 2008-06-06 | 2013-04-30 | Quark Pharmaceuticals, Inc. | Compositions and methods for treatment of ear disorders |
| CN102459596B (zh) * | 2009-05-06 | 2016-09-07 | 库尔纳公司 | 通过针对脂质转运和代谢基因的天然反义转录物的抑制治疗脂质转运和代谢基因相关疾病 |
| HUE026020T2 (en) * | 2009-08-27 | 2016-05-30 | Idera Pharmaceuticals Inc | Preparation for inhibiting gene expression and its uses |
| KR101029699B1 (ko) * | 2010-09-29 | 2011-04-18 | 동국대학교 산학협력단 | 생약추출물을 유효성분으로 함유하는 알쯔하이머 치매 치료 및 예방용 조성물 |
| CN104583398A (zh) * | 2012-05-16 | 2015-04-29 | Rana医疗有限公司 | 用于调节基因表达的组合物和方法 |
| WO2013173637A1 (en) * | 2012-05-16 | 2013-11-21 | Rana Therapeutics, Inc. | Compositions and methods for modulating gene expression |
| WO2013181618A2 (en) * | 2012-05-31 | 2013-12-05 | The Trustees Of Columbia University In The City Of New York | Methods to treat alzheimer's disease using apoe inhibitors |
| EP3191578B1 (en) * | 2014-09-12 | 2020-11-04 | Whitehead Institute for Biomedical Research | Cells expressing apolipoprotein e and uses thereof |
| US20170334977A1 (en) * | 2014-10-20 | 2017-11-23 | The Brigham And Women's Hospital, Inc. | Targeting Apolipoprotein E (APOE) in Neurologic Disease |
| JP2018513986A (ja) * | 2015-04-10 | 2018-05-31 | キョンブク ナショナル ユニバーシティ ホスピタル | コレステロールの蓄積による疾患診断用マーカー組成物及びその利用 |
| WO2017132669A1 (en) * | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
| WO2017134525A1 (en) * | 2016-02-02 | 2017-08-10 | Olix Pharmaceuticals, Inc. | TREATMENT OF ATOPIC DERMATITIS AND ASTHMA USING RNA COMPLEXES THAT TARGET lL4Rα, TRPA1, OR F2RL1 |
| US12037585B2 (en) * | 2019-12-23 | 2024-07-16 | University Of Massachusetts | Oligonucleotides for tissue specific gene expression modulation |
-
2020
- 2020-03-13 CA CA3133241A patent/CA3133241A1/en active Pending
- 2020-03-13 WO PCT/US2020/022748 patent/WO2020190768A1/en not_active Ceased
- 2020-03-13 US US16/818,563 patent/US20200362341A1/en active Pending
- 2020-03-13 JP JP2021555491A patent/JP7687685B2/ja active Active
- 2020-03-13 CN CN202080036085.2A patent/CN113811311A/zh active Pending
- 2020-03-13 AU AU2020239987A patent/AU2020239987A1/en active Pending
- 2020-03-13 EP EP20772940.1A patent/EP3937951A4/en active Pending
-
2025
- 2025-05-15 JP JP2025081846A patent/JP2025156319A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022528487A5 (cg-RX-API-DMAC7.html) | ||
| US20230020192A1 (en) | Compounds and methods for modulating c90rf72 | |
| JP2018516091A5 (cg-RX-API-DMAC7.html) | ||
| JP2023522701A5 (cg-RX-API-DMAC7.html) | ||
| US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
| JP2021533762A5 (cg-RX-API-DMAC7.html) | ||
| JP2022526419A (ja) | 中枢神経系における遺伝子発現を阻害するための組成物及び方法 | |
| JP2021533804A5 (cg-RX-API-DMAC7.html) | ||
| WO2018062510A1 (ja) | オーバーハングを有する二本鎖核酸複合体 | |
| US20250270562A1 (en) | Bis-rnai compounds for cns delivery | |
| WO2023022229A1 (ja) | モルホリノ核酸を含む修飾ヘテロ核酸 | |
| KR20220069103A (ko) | 최소 플루오린 함량을 갖는 작은 간섭 rna의 화학적 변형 | |
| JP2023518268A5 (cg-RX-API-DMAC7.html) | ||
| CN115397436A (zh) | 用于抑制PNPLA3表达的RNAi剂、其药物组合物和使用方法 | |
| EP2062586B1 (en) | Use of low doses of oligonucleotides antisense to tgf-beta1 genes in the treatment of tumors | |
| JP2023538283A (ja) | 代謝症候群の治療のための組成物及び方法 | |
| JP2015516953A (ja) | 発作を減少させるためおよび神経変性症候群を改質するためにタウ発現を調節する方法 | |
| JP7560616B2 (ja) | 膜貫通型セリンプロテアーゼ6(tmprss6)発現を阻害するための組成物および方法 | |
| JP2020531450A (ja) | 調整性reversir(商標)化合物 | |
| JP2019527549A (ja) | 転写プロセシングの調節のための化合物及び方法 | |
| WO2021070959A1 (ja) | 修飾ヘテロ核酸 | |
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| WO2024164008A1 (en) | Products and compositions | |
| JP2025542580A (ja) | 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖rna、およびその使用 | |
| JP6934695B2 (ja) | 核酸医薬とその使用 |